FemTab Sequi discontinued

FemTab Sequi (estradiol valerate, levonorgestrel), indicated for hormone replacement therapy for menopausal symptoms and second-line therapy for the prevention of postmenopausal osteoporosis, has been discontinued.

Merck Serono made the decision following low demand for the product. Nuvelle (estradiol valerate, levonorgestrel) is a suitable alternative.

View Nuvelle drug record

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more